ArticleMolecular and cellular therapies2015

Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach.

Fatemeh Pourrajab et al.PubMed ↗Full text ↗

No numbers read from the abstract.